KALA-AZAR, SUSCEPTIBILITY TO, 2
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.400 |
None |
0.950 |
40 |
3
|
1988 |
2020 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.500 |
None |
1.000 |
5 |
|
1988 |
2011 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.300 |
None |
1.000 |
4 |
|
1988 |
2011 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
4 |
|
1988 |
2011 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.300 |
None |
1.000 |
4 |
|
1988 |
2011 |
Precancerous Conditions
|
group |
Neoplasms
|
Neoplastic Process
|
471
|
18
|
0.300 |
None |
1.000 |
6 |
|
1989 |
2011 |
Condition, Preneoplastic
|
disease |
Neoplasms
|
Neoplastic Process
|
122
|
|
0.300 |
None |
1.000 |
6 |
|
1989 |
2011 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.905 |
95 |
2
|
1991 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.902 |
92 |
3
|
1991 |
2019 |
Multiple Endocrine Neoplasia Type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
145
|
156
|
0.020 |
None |
1.000 |
2 |
|
1991 |
2009 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.400 |
None |
0.948 |
134 |
3
|
1994 |
2020 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
0.947 |
131 |
3
|
1994 |
2020 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.977 |
43 |
1
|
1994 |
2020 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.390 |
None |
0.889 |
9 |
|
1994 |
2007 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.906 |
85 |
2
|
1995 |
2019 |
Malignant neoplasm of urinary bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2113
|
316
|
0.600 |
None |
0.862 |
29 |
2
|
1995 |
2019 |
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2130
|
281
|
0.600 |
None |
0.852 |
27 |
2
|
1995 |
2019 |
Osteoporosis with pseudoglioma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
12
|
37
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.400 |
None |
0.900 |
100 |
3
|
1997 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.400 |
None |
0.898 |
98 |
3
|
1997 |
2019 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.600 |
None |
0.839 |
62 |
4
|
1998 |
2019 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.100 |
None |
0.828 |
58 |
4
|
1998 |
2019 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.100 |
None |
0.828 |
58 |
4
|
1998 |
2019 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.100 |
None |
0.882 |
17 |
3
|
1998 |
2019 |